
biocrates blog
Applications of metabolomics
Metabolomics meets microbiome – Investigating host response with quantitative metabolomics
In my talk, I will present examples of applications of metabolomics in various sample matrices and how to use this powerful tool to study the effects of the microbiome on the host.
Developing a baseline metabolomic signature associated with COVID-19 severity: Insights from prospective trials encompassing 13 U.S. centers
This lunch and learn event, sponsored by biocrates life sciences and hosted by Dr. Candace Guerrero, Assistant Director of the Center for Metabolomics and Proteomics at UMN, will feature presentations on cutting-edge research in metabolomics.
Metabolomics in pharma – Bridging R&D translation barriers
In this lunch & learn event Marissa Jones shared insights on using metabolomics to uncover the “why” behind your research. Examine real-world case studies. and see biocrates technology in action. Learn how metabolomics is making an impact in the pharmaceutical industry.
Standardizing targeted metabolomics studies using Agilent 6495 LC/TQ in concert with biocrates
In this talk, I will discuss how biocrates solutions such as the MxP® Quant 500 XL kit fits seamlessly into the Agilent 6495 LC/TQ platform.
Standardized metabolomics kits for quantitative and reproducible results
In this talk, I will showcase how the MxP® Quant 500 XL kit and WebIDQ™ streamline targeted metabolomics for quantitative and reproducible results.
The new dogma of microbial bile acid metabolism
In my talk, I will present the new dogma of microbial bile acid metabolism.
Characterizing the metabolome in pediatric severe traumatic brain injury
In this talk, I will discuss the characterization of the metabolome in pediatric severe traumatic brain injury.
Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease
In this talk, I will discuss how the comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s disease.
Inosine – Metabolite of the month
Metabolite of the month is your sneak peek into the world of metabolomics. In this month´s article, we took a closer look at inosine.
mGWAS – Integrating metabolomics in genome-wide association studies for more precise results
Combining genome-wide association studies (GWAS) with metabolomics and Mendelian randomization is transforming precision medicine by uncovering causal links between genetic variants and clinical outcomes, rather than just correlations.